Lynx1 Capital Management LP
Top Portfolio Positions
13 positions ·
$388,431,812 total
· as of Sep 30, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
5,404,674 | $127,009,839 | 32.70% | |
| GHRS |
GH Research PLC
Healthcare
|
8,601,189 | $122,997,002 | 31.67% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
700,014 | $46,501,930 | 11.97% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
5,766,090 | $34,192,913 | 8.80% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
7,098,133 | $15,757,855 | 4.06% | |
| TCRX |
TScan Therapeutics, Inc.
Healthcare
|
7,857,347 | $14,300,371 | 3.68% | |
| DTIL |
Precision Biosciences Inc
Healthcare
|
2,085,192 | $11,510,258 | 2.96% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
1,325,848 | $5,303,392 | 1.37% | |
| PASG |
Passage BIO, Inc.
Healthcare
|
623,704 | $5,008,343 | 1.29% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
261,687 | $3,799,695 | 0.98% |
Portfolio Trend
16 quarters · across all stocks
No Holdings History
No holdings records found for this institution in TRAW.